| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cyclin-dependent protein serine/threonine kinase regulator activity | 1.45e-04 | 51 | 40 | 3 | GO:0016538 | |
| GeneOntologyMolecularFunction | cyclin-dependent protein serine/threonine kinase activator activity | 4.61e-04 | 16 | 40 | 2 | GO:0061575 | |
| GeneOntologyCellularComponent | cyclin-dependent protein kinase holoenzyme complex | 2.16e-04 | 61 | 40 | 3 | GO:0000307 | |
| GeneOntologyCellularComponent | protein kinase complex | 3.07e-04 | 170 | 40 | 4 | GO:1902911 | |
| GeneOntologyCellularComponent | transferase complex, transferring phosphorus-containing groups | 4.26e-04 | 335 | 40 | 5 | GO:0061695 | |
| Domain | - | 4.03e-06 | 2 | 38 | 2 | 3.30.170.10 | |
| Domain | CKS | 4.03e-06 | 2 | 38 | 2 | SM01084 | |
| Domain | Cyclin-dep_kinase_reg-sub | 4.03e-06 | 2 | 38 | 2 | IPR000789 | |
| Domain | CKS | 4.03e-06 | 2 | 38 | 2 | PF01111 | |
| Domain | CKS_1 | 4.03e-06 | 2 | 38 | 2 | PS00944 | |
| Domain | CKS_2 | 4.03e-06 | 2 | 38 | 2 | PS00945 | |
| Domain | fn3 | 3.20e-04 | 162 | 38 | 4 | PF00041 | |
| Domain | FN3 | 5.29e-04 | 185 | 38 | 4 | SM00060 | |
| Domain | FN3 | 6.95e-04 | 199 | 38 | 4 | PS50853 | |
| Domain | FN3_dom | 8.35e-04 | 209 | 38 | 4 | IPR003961 | |
| Domain | Ig-like_fold | 1.36e-02 | 706 | 38 | 5 | IPR013783 | |
| Pubmed | Clinical significance and expression of cyclin kinase subunits 1 and 2 in hepatocellular carcinoma. | 1.36e-06 | 2 | 41 | 2 | 19845855 | |
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 26531156 | ||
| Pubmed | 1.36e-06 | 2 | 41 | 2 | 30988159 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 18498131 | ||
| Pubmed | Chromosomal mapping of the human genes CKS1 to 8q21 and CKS2 to 9q22. | 4.06e-06 | 3 | 41 | 2 | 8697818 | |
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 23301842 | ||
| Pubmed | 4.06e-06 | 3 | 41 | 2 | 28939057 | ||
| Pubmed | 8.12e-06 | 4 | 41 | 2 | 2227411 | ||
| Pubmed | 8.12e-06 | 4 | 41 | 2 | 21697511 | ||
| Pubmed | 8.12e-06 | 4 | 41 | 2 | 18625720 | ||
| Pubmed | 2.03e-05 | 6 | 41 | 2 | 22898779 | ||
| Pubmed | A new region of conservation is defined between human and mouse X chromosomes. | 2.03e-05 | 6 | 41 | 2 | 8661129 | |
| Pubmed | Identification of a ten-amino acid proline-rich SH3 binding site. | 2.84e-05 | 7 | 41 | 2 | 8438166 | |
| Pubmed | Cdc20 and Cks direct the spindle checkpoint-independent destruction of cyclin A. | 4.86e-05 | 9 | 41 | 2 | 18471975 | |
| Pubmed | MAD1-dependent recruitment of CDK1-CCNB1 to kinetochores promotes spindle checkpoint signaling. | 4.86e-05 | 9 | 41 | 2 | 30674583 | |
| Pubmed | 6.07e-05 | 10 | 41 | 2 | 19483727 | ||
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | 1.02e-04 | 398 | 41 | 5 | 35016035 | |
| Pubmed | 1.41e-04 | 15 | 41 | 2 | 19786724 | ||
| Pubmed | 2.49e-04 | 1084 | 41 | 7 | 11544199 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | 2.80e-04 | 1105 | 41 | 7 | 35748872 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | 2.99e-04 | 1489 | 41 | 8 | 28611215 | |
| Pubmed | 5.78e-04 | 30 | 41 | 2 | 16420439 | ||
| Pubmed | Interaction network of human early embryonic transcription factors. | 7.69e-04 | 351 | 41 | 4 | 38297188 | |
| Pubmed | 8.80e-04 | 37 | 41 | 2 | 30389914 | ||
| Pubmed | LGALS3BP regulates centriole biogenesis and centrosome hypertrophy in cancer cells. | 8.94e-04 | 639 | 41 | 5 | 23443559 | |
| Pubmed | 9.45e-04 | 371 | 41 | 4 | 15747579 | ||
| Cytoband | Xp22.3 | 1.95e-04 | 23 | 41 | 2 | Xp22.3 | |
| Cytoband | 4p16.3 | 2.65e-03 | 85 | 41 | 2 | 4p16.3 | |
| GeneFamily | Fibronectin type III domain containing | 1.20e-03 | 160 | 24 | 3 | 555 | |
| Coexpression | MORI_LARGE_PRE_BII_LYMPHOCYTE_UP | 1.09e-05 | 88 | 41 | 4 | M19287 | |
| Coexpression | MORI_IMMATURE_B_LYMPHOCYTE_DN | 1.25e-05 | 91 | 41 | 4 | M18917 | |
| Coexpression | MORI_IMMATURE_B_LYMPHOCYTE_DN | 1.36e-05 | 93 | 41 | 4 | MM1138 | |
| Coexpression | MORI_LARGE_PRE_BII_LYMPHOCYTE_UP | 1.36e-05 | 93 | 41 | 4 | MM1137 | |
| Coexpression | PAL_PRMT5_TARGETS_UP | 1.62e-05 | 204 | 41 | 5 | M10688 | |
| Coexpression | PAL_PRMT5_TARGETS_UP | 1.87e-05 | 210 | 41 | 5 | MM1172 | |
| Coexpression | MARKEY_RB1_ACUTE_LOF_UP | 3.33e-05 | 237 | 41 | 5 | M15606 | |
| Coexpression | MARKEY_RB1_ACUTE_LOF_UP | 3.54e-05 | 240 | 41 | 5 | MM976 | |
| Coexpression | TRAVAGLINI_LUNG_PROLIFERATING_NK_T_CELL | 4.92e-05 | 129 | 41 | 4 | M41687 | |
| Coexpression | HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP | 9.55e-05 | 153 | 41 | 4 | M5588 | |
| Coexpression | HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP | 1.00e-04 | 155 | 41 | 4 | MM1259 | |
| Coexpression | GSE13547_2H_VS_12_H_ANTI_IGM_STIM_BCELL_DN | 1.94e-04 | 184 | 41 | 4 | M2982 | |
| Coexpression | GSE28737_WT_VS_BCL6_KO_MARGINAL_ZONE_BCELL_UP | 2.62e-04 | 199 | 41 | 4 | M9345 | |
| Coexpression | GSE19198_CTRL_VS_IL21_TREATED_TCELL_1H_DN | 2.62e-04 | 199 | 41 | 4 | M7222 | |
| Coexpression | GSE3982_NEUTROPHIL_VS_TH1_DN | 2.62e-04 | 199 | 41 | 4 | M5533 | |
| Coexpression | GSE339_CD8POS_VS_CD4CD8DN_DC_IN_CULTURE_UP | 2.67e-04 | 200 | 41 | 4 | M5127 | |
| Coexpression | GSE24634_TEFF_VS_TCONV_DAY7_IN_CULTURE_DN | 2.67e-04 | 200 | 41 | 4 | M4624 | |
| Coexpression | GSE17301_IFNA2_VS_IFNA5_STIM_ACD3_ACD28_ACT_CD8_TCELL_DN | 2.67e-04 | 200 | 41 | 4 | M8037 | |
| Coexpression | HALLMARK_E2F_TARGETS | 2.67e-04 | 200 | 41 | 4 | M5925 | |
| Coexpression | GSE16385_UNTREATED_VS_12H_ROSIGLITAZONE_IFNG_TNF_TREATED_MACROPHAGE_UP | 2.67e-04 | 200 | 41 | 4 | M7889 | |
| Coexpression | GSE39110_DAY3_VS_DAY6_POST_IMMUNIZATION_CD8_TCELL_DN | 2.67e-04 | 200 | 41 | 4 | M9277 | |
| Coexpression | GSE40666_NAIVE_VS_EFFECTOR_CD8_TCELL_UP | 2.67e-04 | 200 | 41 | 4 | M9203 | |
| Coexpression | GSE20715_0H_VS_48H_OZONE_TLR4_KO_LUNG_DN | 2.67e-04 | 200 | 41 | 4 | M4386 | |
| Coexpression | GSE8621_UNSTIM_VS_LPS_PRIMED_UNSTIM_MACROPHAGE_DN | 2.67e-04 | 200 | 41 | 4 | M6980 | |
| Coexpression | MORI_PRE_BI_LYMPHOCYTE_UP | 2.78e-04 | 81 | 41 | 3 | M1395 | |
| Coexpression | MORI_PRE_BI_LYMPHOCYTE_UP | 3.44e-04 | 87 | 41 | 3 | MM1136 | |
| Coexpression | LE_NEURONAL_DIFFERENTIATION_DN | 4.01e-04 | 19 | 41 | 2 | M2441 | |
| ToppCell | E16.5-samps|World / Age Group, Lineage, Cell class and subclass | 1.06e-05 | 149 | 41 | 4 | e94d075f68c1c70c89fab50b1b765b5dda650d09 | |
| ToppCell | (03)_Secretory-(2)_48hpi|(03)_Secretory / shred by cell type and Timepoint | 1.24e-05 | 155 | 41 | 4 | d3b3d5764dfccaa4564f6063da7e13633a4f4b73 | |
| ToppCell | (1)_Control_(PBS)-(4)_COL2.3+_osteoblasts|(1)_Control_(PBS) / Stress and Cell class | 1.41e-05 | 160 | 41 | 4 | 8450466fc2465c56798df2b520edd23c2c2e941c | |
| ToppCell | PND10-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.91e-05 | 173 | 41 | 4 | 12c6875f881cb0fbff09d753b53c1cce7a95527f | |
| ToppCell | PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD8_T-CD8_T_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.00e-05 | 175 | 41 | 4 | 8958c5c30437d20a4abd70d7527990f7e2a68b93 | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.00e-05 | 175 | 41 | 4 | d43ae33a6256606ce848247cad32d74f21b38988 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.09e-05 | 177 | 41 | 4 | 2b63f0529ef73e0eede9b7ef1f08b0a0426a9c82 | |
| ToppCell | PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.09e-05 | 177 | 41 | 4 | 3081ce5fc66a1bb833719d6c0e0a6fc7115eeb91 | |
| ToppCell | facs-Marrow-KLS-24m-Hematologic-MPP_Fraction_B_+_C|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.19e-05 | 179 | 41 | 4 | 5297f7459b40ca780a1983fecc1bb9c035c7677e | |
| ToppCell | facs-Thymus-Flowthrough-24m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.54e-05 | 186 | 41 | 4 | 202e1514954a5a654f7588bed72cd12db513bb19 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_proliferating|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.54e-05 | 186 | 41 | 4 | 5d527050cd554cc46c6d8dcb7981900725d79fc6 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_proliferating-Lymphatic_EC_proliferating_L.2.5.4.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.54e-05 | 186 | 41 | 4 | ee1c3e2adfa2900542200a218746b576c7ed10dc | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Proliferating_Classical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.65e-05 | 188 | 41 | 4 | a6ad6de6aeaf213952124252c1452b73942a0c3d | |
| ToppCell | P07-Mesenchymal-developing_mesenchymal_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.82e-05 | 191 | 41 | 4 | ddbc5f97f2aef19be4ad93db4139876c939b848e | |
| ToppCell | Endothelial-Endothelial-D_(cycle)|Endothelial / shred on cell class and cell subclass (v4) | 2.82e-05 | 191 | 41 | 4 | a3c5a913a99f17633c140ec9ece81b73e59e0715 | |
| ToppCell | wk_20-22-Hematologic-Myeloid-Cycling_DC|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.82e-05 | 191 | 41 | 4 | 1da569ebcfab4e1a95315430ae77a17a1f119263 | |
| ToppCell | facs-Thymus-Flowthrough-3m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.88e-05 | 192 | 41 | 4 | e8d47504b744040a762ec9b670a66cc060b2ae86 | |
| ToppCell | P07-Endothelial-proliferative_endothelial_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.94e-05 | 193 | 41 | 4 | 1e95ef29357969ee385b4717c0b5a497390ac260 | |
| ToppCell | facs-Thymus-Flowthrough-24m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.94e-05 | 193 | 41 | 4 | fd5a5ead966abe385a22d61a721f9fb1605876f6 | |
| ToppCell | droplet-Tongue-Unstain-18m-Epithelial-basal_cell_of_epidermis|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.94e-05 | 193 | 41 | 4 | 63205026e20cf2c7bfb7d08bba48d5df7976ccca | |
| ToppCell | P07-Endothelial-proliferative_endothelial_cell-proliferative_endothelial_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.94e-05 | 193 | 41 | 4 | 0f21fb8b35f89f4c1c8109d1a4d3d08a452f9edd | |
| ToppCell | facs-Thymus-Flowthrough-24m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.00e-05 | 194 | 41 | 4 | 5d60262a512590d60bc795d9a0e03c0219e3e15e | |
| ToppCell | P03-Endothelial-proliferative_endothelial_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.00e-05 | 194 | 41 | 4 | 22bcfb0f3f73608feb22c0847ab4d34f87aeede0 | |
| ToppCell | P03-Endothelial-proliferative_endothelial_cell-proliferative_endothelial_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.00e-05 | 194 | 41 | 4 | 5e56ce9b9fe0721be3a9e6efe1422599bb867721 | |
| ToppCell | metastatic_Lymph_Node-B_lymphocytes-GC_B_cells_in_the_DZ|metastatic_Lymph_Node / Location, Cell class and cell subclass | 3.06e-05 | 195 | 41 | 4 | 3c5b7cce4a1c4b28fa3b657cce4148669a59e55e | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.06e-05 | 195 | 41 | 4 | e9c7eb0b1a2d58f69b4e839665101948bd4527b8 | |
| ToppCell | droplet-Thymus-nan-3m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.06e-05 | 195 | 41 | 4 | 7ae732f100e9a3c6062be5b877efa1ec9d5b3958 | |
| ToppCell | droplet-Thymus-nan-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.06e-05 | 195 | 41 | 4 | 043e2f19d95e94cd5219e2c415f322ed340aa80f | |
| ToppCell | severe-T/NK_proliferative|severe / disease stage, cell group and cell class | 3.12e-05 | 196 | 41 | 4 | 89f005216770dbb84378f5d1f20ca11b0ce40faa | |
| ToppCell | mild-Lymphocytic-Prol._cells|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 3.12e-05 | 196 | 41 | 4 | b1d9866d5dfaefdb8bedaf01a750d97987acb3d1 | |
| ToppCell | droplet-Thymus-nan-18m-Lymphocytic-DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.12e-05 | 196 | 41 | 4 | 5ddd314d3def3776dc7da83778d41c6436ca51ac | |
| ToppCell | control-Lymphocytic-Prol._cells|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 3.12e-05 | 196 | 41 | 4 | 886f7c865b086d6ebb4a1746865c30af6bbed345 | |
| ToppCell | droplet-Thymus-nan-3m-Lymphocytic-DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.18e-05 | 197 | 41 | 4 | 9b2c67de46bd59bf56c81a0d10b84cf4a041c120 | |
| ToppCell | droplet-Thymus-nan-21m-Lymphocytic-DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.18e-05 | 197 | 41 | 4 | f84f0ddf51208764ab56408d97035bbff562e59d | |
| ToppCell | droplet-Thymus-nan-21m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.18e-05 | 197 | 41 | 4 | a0d463825b62de49466f9fa563405dda4387cfff | |
| ToppCell | metastatic_Lymph_Node-T/NK_cells-Undetermined|metastatic_Lymph_Node / Location, Cell class and cell subclass | 3.24e-05 | 198 | 41 | 4 | f9f083c76c51b6f014ecf80eaec957eff8d1ab75 | |
| ToppCell | metastatic_Lymph_Node-B_lymphocytes-GC_B_cells_in_the_DZ|B_lymphocytes / Location, Cell class and cell subclass | 3.24e-05 | 198 | 41 | 4 | 21c4762ca8591804cf77a23b64470e60d25c5357 | |
| ToppCell | B_cell_maturation-pre-B|B_cell_maturation / Lineage and Cell class | 3.31e-05 | 199 | 41 | 4 | 4bf6a656de04d92103cbe743cd07afd9d125c654 | |
| ToppCell | remission-T/NK_proliferative|World / disease stage, cell group and cell class | 3.31e-05 | 199 | 41 | 4 | f305f3a454b7d2170429bad087480ccccca19acd | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.31e-05 | 199 | 41 | 4 | 4394dcd1809f49e9bada8f5e115d5123356eae3e | |
| ToppCell | remission-T/NK_proliferative|remission / disease stage, cell group and cell class | 3.31e-05 | 199 | 41 | 4 | 303a5fc43a48b05b6f2060d99eef4adc36f8d4e3 | |
| ToppCell | COVID-19_Convalescent-Lymphoid_T/NK-T/NK_proliferative|COVID-19_Convalescent / Disease group, lineage and cell class | 3.31e-05 | 199 | 41 | 4 | 893b78c661c529db07a5fcc3124d9b3d0f270fa5 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.31e-05 | 199 | 41 | 4 | c0ea391bb347b99b94b5d7f02612ede938986745 | |
| ToppCell | COVID-19_Convalescent-T/NK_proliferative|COVID-19_Convalescent / Disease condition and Cell class | 3.31e-05 | 199 | 41 | 4 | c608d953b852b67a4e36bd63d45f0deec3eefbd9 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.31e-05 | 199 | 41 | 4 | 5b18e18ddbf4bd53aa0d574d23092cb96da7f400 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-Other_T|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.31e-05 | 199 | 41 | 4 | 6df65f4c2f9a125e0c7c4f597fefc05a97fc8831 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-Other_T|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.31e-05 | 199 | 41 | 4 | cb229aa3eb7b1cc47e76711b8fc18fce88a5cf08 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Hematopoietic-B_cells-Cycling_B_cell|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.31e-05 | 199 | 41 | 4 | 0cae9c80c15542fd86a82d7b6d6a3ad690cee410 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.31e-05 | 199 | 41 | 4 | 96af1f289552f38f2dfa181192eb3276f4c7d70b | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like-AC-like_Prolif-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.31e-05 | 199 | 41 | 4 | 89d7622c4ae146900d963ac68c6bf011e8674665 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like-AC-like_Prolif|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.37e-05 | 200 | 41 | 4 | 0de9e7412a1725a8acd51820aa3135a112ced36c | |
| ToppCell | MS-IIF-Lymphocyte-T/NK-T/NK_proliferative|IIF / Disease, condition lineage and cell class | 3.37e-05 | 200 | 41 | 4 | c7c1806a1054b2b034a26a18aac93fc3bec4dbc8 | |
| ToppCell | tumor_Lymph_Node_/_Brain-T/NK_cells-Undetermined|T/NK_cells / Location, Cell class and cell subclass | 3.37e-05 | 200 | 41 | 4 | cfec2f712b870797fab3b0770f16feaafd37e8d5 | |
| ToppCell | COVID-19-COVID-19_Convalescent-Lymphocyte-T/NK-T/NK_proliferative|COVID-19_Convalescent / Disease, condition lineage and cell class | 3.37e-05 | 200 | 41 | 4 | 00538c4cbab5da00b3a366717d38a3ba5cfe3f65 | |
| ToppCell | 356C-Myeloid-Dendritic-cDC_proliferating_1|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 3.37e-05 | 200 | 41 | 4 | 548a0f486ab8745da107f2815914dbf873a6e3c8 | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-T/NK-T/NK_proliferative|COVID-19_Severe / Disease, condition lineage and cell class | 3.37e-05 | 200 | 41 | 4 | 0892603e604c2a945dd720685d45970f855bd5d3 | |
| ToppCell | Sepsis-Int-URO-Lymphocyte-T/NK-dn_T|Int-URO / Disease, condition lineage and cell class | 3.37e-05 | 200 | 41 | 4 | 020439d9e70fff7246650ab0e9105236688c3ec3 | |
| ToppCell | Sepsis-Int-URO-Lymphocyte-T/NK-T/NK_proliferative|Int-URO / Disease, condition lineage and cell class | 3.37e-05 | 200 | 41 | 4 | 99acc1ea01288efdd5b166aa20d66735f2bbe543 | |
| ToppCell | Entopeduncular-Macroglia-OLIGODENDROCYTE|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 2.32e-04 | 130 | 41 | 3 | 0a6b87635e650df431a88f2e6396abead84d901d | |
| ToppCell | Endothelial-H_(cycle)|World / shred on cell class and cell subclass (v4) | 2.48e-04 | 133 | 41 | 3 | 8e3005114761feee028c496cc739e607b35d7831 | |
| ToppCell | Endothelial-Endothelial-H_(cycle)|Endothelial / shred on cell class and cell subclass (v4) | 2.76e-04 | 138 | 41 | 3 | a1f41a5a9da40adcc343722baef78c603599c3f0 | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-Alveolar_Mac|Myeloid_cells / Location, Cell class and cell subclass | 2.94e-04 | 141 | 41 | 3 | 399380de5ea09e22fd128e3e55fffeffc4874c15 | |
| ToppCell | Lymphoid-T_cells_(cycle)|World / shred on cell class and cell subclass (v4) | 3.07e-04 | 143 | 41 | 3 | 2fbcca395971a8452f68481282a74cec4005d1e2 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Reln_Itm2a|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.13e-04 | 144 | 41 | 3 | 0bbe670454846cf9bc7464ae4e91488415c4111d | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-AC-like-AC-like_Prolif|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.67e-04 | 152 | 41 | 3 | f748ee34167f79ecda116aa1914afab47403385a | |
| ToppCell | TCGA-Thymus-Primary_Tumor-Thymoma-Type_B2|TCGA-Thymus / Sample_Type by Project: Shred V9 | 3.67e-04 | 152 | 41 | 3 | 752fdd3d55f5ad5a21562934a218e1fd50d152b1 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.67e-04 | 152 | 41 | 3 | 1b2a39ae159e79f1fb18d6d164bd7acab5299fca | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD8_T-CD8_T_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.81e-04 | 154 | 41 | 3 | f78b01c19afcbab6319f61e4d6023ecb3d510d24 | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.81e-04 | 154 | 41 | 3 | 46155f36d3983f637b55d7525b675c8828f6ab2e | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.81e-04 | 154 | 41 | 3 | 71ffc23a2e02e27cabbdbeaa622e59e9f4a4cd9d | |
| ToppCell | Control-Hematopoietic_Meg-Ery-Platelets-Platelets|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.11e-04 | 158 | 41 | 3 | f2c39b2eff8f2728a9d482d88e0d04984306a3fd | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Club|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 4.11e-04 | 158 | 41 | 3 | 03281e87780e3bacd089903383c016d03c373bf7 | |
| ToppCell | COPD-Epithelial-Aberrant_Basaloid|Epithelial / Disease state, Lineage and Cell class | 4.11e-04 | 158 | 41 | 3 | 8f66979e92f886d86cecbd26aaa0c5915c049734 | |
| ToppCell | 18-Distal-Epithelial-Basal_cell|Distal / Age, Tissue, Lineage and Cell class | 4.11e-04 | 158 | 41 | 3 | 183f445967e09e871c93d8e94781ed9fec894169 | |
| ToppCell | Control-Hematopoietic_Meg-Ery-Platelets|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.11e-04 | 158 | 41 | 3 | fa9797a23254070c569fabe8a314b3e8b3ae9ebd | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK-NK_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.58e-04 | 164 | 41 | 3 | ae09e5aabd1347b865474255e7411c04f63efb3b | |
| ToppCell | PND28-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-Treg|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.58e-04 | 164 | 41 | 3 | e5258efd6765acfc394708f697ec76acaef09079 | |
| ToppCell | LPS-antiTNF-Epithelial_airway-Mes-Epi-like|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.58e-04 | 164 | 41 | 3 | 4307b002fb41ddfc7ab8a6bca66a60942c250052 | |
| ToppCell | facs-Marrow-T-cells-24m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.58e-04 | 164 | 41 | 3 | 2a230ea066decb798a0e6f2b96c7608c8e608031 | |
| ToppCell | LPS-antiTNF-Epithelial_airway-Mes-Epi-like-Airway|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.58e-04 | 164 | 41 | 3 | 1d84aa5b925f502ee9c5fa39714490f613a58028 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Tpbg|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.58e-04 | 164 | 41 | 3 | f0499e6c1b17c4df72b18b294e3b53ef723da2ac | |
| ToppCell | facs-Marrow-T-cells-24m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.58e-04 | 164 | 41 | 3 | d02d39edd0bfef5a53b814ec6d5f026d41253218 | |
| ToppCell | PND03-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.66e-04 | 165 | 41 | 3 | 26c750f10f6401752e2e63d91dc844c81b29d735 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Reln_Tac1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.66e-04 | 165 | 41 | 3 | d8df50f5a3b646e8ea13739fdc65ce6f39b4d4d2 | |
| ToppCell | droplet-Skin-nan-18m-Epithelial-stem_cell_of_epidermis|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.66e-04 | 165 | 41 | 3 | 96f0d8bc9b13e23f757e6bb98cd7dc061a8a9564 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Reln_Tac1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.74e-04 | 166 | 41 | 3 | 59d47c1fca7a8c70f6998f3367a9dbcb9b67966f | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD4_T-CD4_T_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.74e-04 | 166 | 41 | 3 | a41a20cef053c67da2d435e3e132ce28f1661c03 | |
| ToppCell | droplet-Spleen-nan-3m-Myeloid-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.74e-04 | 166 | 41 | 3 | c1f18de4a1a2b6cdc703e6d29d136e1134fcbdf3 | |
| ToppCell | droplet-Spleen-nan-3m-Myeloid|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.74e-04 | 166 | 41 | 3 | 94c30d6ca179d0cb02a5ed0093c5a2871e17ae50 | |
| ToppCell | PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-Treg-Treg_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.83e-04 | 167 | 41 | 3 | d21635df8b74189e3309eaf435af381fbe412574 | |
| ToppCell | facs-Limb_Muscle-forelimb_and_hindlimb-18m-Lymphocytic-T_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.91e-04 | 168 | 41 | 3 | 182f08106ac65ea501e2fb9139d3b44b7c4662c9 | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.00e-04 | 169 | 41 | 3 | 4db49b7eaea34e6558ee73b01e76315e99cc880b | |
| ToppCell | PND03-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD4_T-CD4_T_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.08e-04 | 170 | 41 | 3 | 2d5e56eee0c3ce75a9641cc14dee0e0807141c32 | |
| ToppCell | ILEUM-non-inflamed-(1)_T_cell-(1)_Central_Memory_T_cells|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 5.08e-04 | 170 | 41 | 3 | d4c95c317a731c0db2c213c64cb87da636d30f00 | |
| ToppCell | droplet-Fat-Bat-18m|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.08e-04 | 170 | 41 | 3 | c720d81bc29a8fd1f1249c6af408471d561f1d5d | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_B_(ET)-Glut_ET_L5_FEZF2-Exc_L5_FEZF2_SCN7A|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.08e-04 | 170 | 41 | 3 | a0047551619547971d55165156f61f090948f902 | |
| ToppCell | droplet-Fat-Bat|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.08e-04 | 170 | 41 | 3 | c4ecdfc2b4710da0a5fbb20e9df02536023badb1 | |
| ToppCell | PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.08e-04 | 170 | 41 | 3 | b04e2f84024baaae9b4ff19bdac8c69afdb92a76 | |
| ToppCell | 10x5'-Liver-Myeloid_Mac-Intermediate_macrophages|Liver / Manually curated celltypes from each tissue | 5.17e-04 | 171 | 41 | 3 | 25e0333743affdb662223fb5220b8a61fa02ad9f | |
| ToppCell | E18.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-Sox9_Epi-Sox9_Epi_G2M|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.17e-04 | 171 | 41 | 3 | 621f9da0bfa09c86fc89fd26919403e94cd56d2b | |
| Computational | Neighborhood of CENPE | 1.41e-04 | 41 | 27 | 3 | GNF2_CENPE | |
| Computational | Neighborhood of CKS2 | 2.56e-04 | 50 | 27 | 3 | GNF2_CKS2 | |
| Computational | Neighborhood of CDC20 | 3.59e-04 | 56 | 27 | 3 | GNF2_CDC20 | |
| Computational | Neighborhood of RFC4 | 4.40e-04 | 60 | 27 | 3 | GNF2_RFC4 | |
| Computational | Neighborhood of CCNA2 | 6.35e-04 | 68 | 27 | 3 | GNF2_CCNA2 | |
| Disease | response to angiotensin-converting enzyme inhibitor, response to angiotensin receptor blocker, angioedema | 5.70e-04 | 26 | 40 | 2 | EFO_0005325, EFO_0005532, EFO_0010735 | |
| Disease | eye disease | 1.71e-03 | 45 | 40 | 2 | EFO_0003966 | |
| Disease | Myopia | 1.80e-03 | 385 | 40 | 4 | HP_0000545 | |
| Disease | Male sterility | 1.94e-03 | 48 | 40 | 2 | C0917731 | |
| Disease | Male infertility | 1.94e-03 | 48 | 40 | 2 | C0021364 | |
| Disease | Subfertility, Male | 1.94e-03 | 48 | 40 | 2 | C0848676 | |
| Disease | refractive error, age at onset, Myopia | 2.28e-03 | 193 | 40 | 3 | EFO_0004847, HP_0000545, MONDO_0004892 | |
| Disease | Colorectal Carcinoma | 2.48e-03 | 702 | 40 | 5 | C0009402 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LHPLPAQPHLKRVRP | 66 | Q96EY9 | |
| LVKKEPPAPHRHTPQ | 286 | Q9HCM7 | |
| RLRRKQPLHPLNPCP | 36 | P22674 | |
| VLPRPEKPQLPHLQR | 401 | P78314 | |
| RKRPPRQKPLGHSLH | 76 | Q5T686 | |
| PELPANSPHPLKLRR | 681 | P51793 | |
| PARPPPHNKHLARVA | 11 | Q99618 | |
| NPHHLPLRPILRPRK | 311 | P11161 | |
| PRLPSPQQHHRILRL | 526 | Q68DA7 | |
| PHPPGPRILDLRQHL | 501 | Q6NSJ2 | |
| PRPSLQPHPRLLDHR | 346 | Q14626 | |
| HNAHLRGPPPKLIPV | 116 | Q9BRK4 | |
| AIKHLPRPETLHPNP | 756 | Q9NR82 | |
| RGPRSHQKLQPPPLL | 291 | Q6ZUT6 | |
| PQLLHIIPCPRHRIP | 291 | Q9H3H5 | |
| TELLPKRPQHLPGHP | 556 | P54098 | |
| RARHKKHTPQHPVPP | 271 | Q9UPM6 | |
| PLRPLKHPSHKPRGR | 241 | A6NFR6 | |
| PPRVLGRPKHKEVHL | 676 | Q53EP0 | |
| PLSQLPAPQHPKIRL | 26 | P38484 | |
| TQPPPHLPTKLVIRH | 1236 | Q9NZM4 | |
| HPPLLPDRPRDHVKK | 256 | O95377 | |
| KRPHRQHPGILKLPH | 46 | Q9H7H0 | |
| VGPRPHQPRILKHLP | 546 | Q5SV97 | |
| HQPRILKHLPRPPPS | 551 | Q5SV97 | |
| CRQPPHALRPLLLLP | 11 | Q496H8 | |
| LRPKRQPPLHLPLAD | 616 | Q6ZW31 | |
| KEVPRHLRQPGIHPK | 156 | Q14493 | |
| LPLHVALHPPEPCRR | 736 | Q24JP5 | |
| PDVRHHHLPKTKPLP | 256 | Q5VWT5 | |
| PLPEALLPPKQQHLR | 1146 | Q13796 | |
| KFPLPHRVLRRQHKP | 151 | Q02543 | |
| PTKRRPPQPLHQVHR | 26 | Q96KW2 | |
| HHPRVLKNRPPPARL | 1211 | Q8TER0 | |
| RAPPILPPHLLQVIL | 201 | Q9Y478 | |
| KFNIRPRQPHHDLPP | 46 | Q9H2A9 | |
| EPEPHILLFRRPLPK | 61 | P61024 | |
| EPEPHILLFRRPLPK | 61 | P33552 | |
| PALHLTVQRLKLPPP | 806 | Q9C0B9 | |
| QHCQLEKPLRHPPLP | 1096 | Q9NRJ4 | |
| PPPLAPAQLRHRLRH | 141 | Q96K62 | |
| PVPKPKPHVSDHNRL | 286 | Q9P2T0 | |
| KTDRPALHLRIPPQP | 2096 | O14686 | |
| KRPPPPPRRTHSLHQ | 436 | Q9P206 | |
| RLKIAQPLHLPPRPD | 1181 | Q8IZF0 |